PMID: 6985989Feb 1, 1980Paper

The Achilles heel of the University Group Diabetes Program

JAMA : the Journal of the American Medical Association
C KiloJ R Williamson

Abstract

The controversial conclusions of University Group Diabetes Program (UGDP) investigators are refuted by new findings uncovered by analyses of patient data obtained from the UGDP Coordinating Center and by critical review of data previously published by UGDP investigators and the Biometric Committee. These new findings (1) document a notable discrepancy in the sex ratio of cardiovascular (CV) death rates in placebo-treated subjects, (2) show that all excess CV mortality in tolbutamide-treated subjects was restricted to a relatively small group of poorly controlled diabetics, and (3) provide evidence that insulin was efficacious in reducing CV deaths. The anomalous sex ratio of CV deaths in UGDP placebo-treated subjects dictates the conclusion that the CV death rate in placebo-treated subjects was spuriously low, giving the false impression of increased death rates in the other treatment groups, thereby accounting for all of the controversial observations reported by UGDP investigators. For this reason UGDP conclusions based on comparison with placebo-treated subjects should not be extrapolated to the general diabetic population.

Citations

May 1, 1981·Controlled Clinical Trials·T C ChalmersA Ambroz
Oct 1, 1987·Postgraduate Medical Journal·R B Tattersall, A R Scott
May 25, 2011·Expert Opinion on Drug Safety·Devindra SehraShiv Tej Sehra
Aug 1, 1981·Atherosclerosis·P N Hopkins, R R Williams
Oct 28, 1999·American Heart Journal·M N Feinglos, M A Bethel
May 5, 2001·Expert Opinion on Pharmacotherapy·A L McCall
Feb 28, 2001·Diabetes, Obesity & Metabolism·L G Howes
Sep 3, 2002·Statistics in Medicine·Jeffrey D Blume
Sep 28, 1999·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·R E GlasgowJ Norman
Feb 23, 2008·Anesthesiology·Hema S BagryFranco Carli
Nov 26, 2010·Science and Engineering Ethics·Beth A Fischer, Michael J Zigmond

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.